Fair Money & Economic Opportunity

Tandem Diabetes Care offers an interest-free payment plan for its medical devices, with monthly payments as low as $50 for up to 48 months and a $0 down payment.

More than 30% of customers pay $0 out of pocket. A $6.50 monthly processing fee is applied to these payments. The company does not offer consumer credit products, therefore, there are no APRs or high-cost financial products to evaluate beyond the payment plan. Tandem experienced a security incident between January 17-20, 2020, involving five employee email accounts, which exposed customer contact information, clinical data, and in some cases, Social Security numbers for 140,781 individuals. The company offers a 90-day return policy for direct orders in the United States. The flexible payment plan is not available in all states and excludes residents of Florida, as well as potential pump users using Medicare, Medicaid, Tricare, or other federal or state health programs. The company provides products and support in multiple countries. Tandem Mobi, a mini-pump, is operated solely by a smartphone, and the company emphasizes automation, personalization, and simplification in its algorithm development.

Fair Trade & Ethical Sourcing

Tandem Diabetes Care has a Supplier Code of Conduct that outlines ethical requirements for its suppliers, covering aspects such as human trafficking, child labor, and responsible sourcing, including conflict minerals.

Written supply agreements require suppliers to comply with applicable laws, including those regarding slavery and human trafficking. The company conducts Supplier Performance Evaluations at scheduled intervals and requires suppliers to follow Supplier Corrective Action Requests. The California Transparency in Supply Chains Act (SB 657) is also noted as a relevant regulatory action. However, the provided articles do not contain specific quantitative data for any of the defined KPIs, such as the percentage of fair-trade certified spend, audit frequency, number of forced or child labor incidents, traceability coverage, remediation speed, percentage of contracts with ethical clauses, share of high-risk materials, or supplier diversity spend. Therefore, no KPIs can be scored.

Honest & Fair Business

Tandem Diabetes Care maintains a comprehensive whistleblower policy with a confidential reporting system hosted by a third party, offering online and 24/7 toll-free phone services for anonymous reporting by employees, customers, and suppliers, explicitly prohibiting retaliation.

The company's policies mandate compliance with the U.S. Foreign Corrupt Practices Act (FCPA) and similar international anti-bribery laws, acknowledging operations in regions with governmental corruption. The company has an FCPA-compliant policy in place, and employees who interact with Health Care Professionals receive training on the HCP Policy, anti-kickback statute, and fraud prevention. Tandem requires suppliers to abide by all applicable anti-corruption laws and regulations, including the FCPA. The company requires suppliers to perform periodic evaluations/audits of their facilities and operations, including subcontractors, to ensure compliance with its Code of Conduct and applicable law. Tandem or its designee must be able to access and conduct an independent evaluation of supplier compliance. However, the extent of independent verification of Tandem's own ethical claims is not specified beyond supplier audits. A class-action lawsuit alleges negligence in a January 2020 phishing attack that exposed the protected health information of over 140,000 individuals, claiming violations of the Confidentiality of Medical Information Act (CMIA).

No War, No Weapons

Tandem Diabetes Care's due diligence for conflict minerals is based on the five-step framework of the OECD Guidance.

The company annually requests its direct suppliers to complete the Responsible Minerals Initiative CMRT to obtain information on conflict minerals, with 20 suppliers responding in 2024. However, the company is unable to determine whether the conflict minerals present in its products originate in the Covered Countries, and its products contain conflict minerals necessary for production or functionality. No independent private sector audit of its conflict minerals report has been conducted. The company's Conflict Minerals Policy was adopted in February 2015 and amended in 2018.